These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Dopaminergic and muscarinic regulation of striatal enkephalin and substance P messenger RNAs following striatal dopamine denervation: effects of systemic and central administration of quinpirole and scopolamine. Nisenbaum LK; Kitai ST; Gerfen CR Neuroscience; 1994 Nov; 63(2):435-49. PubMed ID: 7534387 [TBL] [Abstract][Full Text] [Related]
23. Dopamine D2 receptor-dependent modulation of striatal NO synthase activity. Sammut S; Bray KE; West AR Psychopharmacology (Berl); 2007 Apr; 191(3):793-803. PubMed ID: 17206493 [TBL] [Abstract][Full Text] [Related]
24. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies. Hu XT; White FJ Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772 [TBL] [Abstract][Full Text] [Related]
25. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats. Pollack AE; Yates TM Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212 [TBL] [Abstract][Full Text] [Related]
26. Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. Ichikawa J; Chung YC; Li Z; Dai J; Meltzer HY Brain Res; 2002 Dec; 958(1):176-84. PubMed ID: 12468043 [TBL] [Abstract][Full Text] [Related]
27. A within-subjects microdialysis/behavioural study of the role of striatal acetylcholine in D1-dependent turning. Acquas E; Fenu S; Loddo P; Di Chiara G Behav Brain Res; 1999 Sep; 103(2):219-28. PubMed ID: 10513590 [TBL] [Abstract][Full Text] [Related]
28. Role of NMDA and AMPA glutamate receptors in the induction and the expression of dopamine-mediated sensitization in 6-hydroxydopamine-lesioned rats. Pollack AE; St Martin JL; MacPherson AT Synapse; 2005 Apr; 56(1):45-53. PubMed ID: 15700284 [TBL] [Abstract][Full Text] [Related]
29. Regulation of dopamine D1 and D2 receptors on striatal acetylcholine release in rats. Ikarashi Y; Takahashi A; Ishimaru H; Arai T; Maruyama Y Brain Res Bull; 1997; 43(1):107-15. PubMed ID: 9205804 [TBL] [Abstract][Full Text] [Related]
30. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats. Pollack AE; Turgeon SM; Fink JS Neuroscience; 1997 Jul; 79(1):79-93. PubMed ID: 9178866 [TBL] [Abstract][Full Text] [Related]
31. Differential effects of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats. Xu M; Mizobe F; Yamamoto T; Kato T Brain Res; 1989 Aug; 495(2):232-42. PubMed ID: 2765928 [TBL] [Abstract][Full Text] [Related]
32. Measurement of plasmalemmal dopamine transport, vesicular dopamine transport, and K(+)-stimulated dopamine release in frozen rat brain tissue. Volz TJ; Farnsworth SJ; Hanson GR; Fleckenstein AE J Neurosci Methods; 2009 Jun; 180(2):317-20. PubMed ID: 19464519 [TBL] [Abstract][Full Text] [Related]
33. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. Paul ML; Graybiel AM; David JC; Robertson HA J Neurosci; 1992 Oct; 12(10):3729-42. PubMed ID: 1357113 [TBL] [Abstract][Full Text] [Related]
34. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion. Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981 [TBL] [Abstract][Full Text] [Related]
35. Muscarinic receptors regulate striatal neuropeptide gene expression in normal and amphetamine-treated rats. Wang JQ; McGinty JF Neuroscience; 1996 Nov; 75(1):43-56. PubMed ID: 8923522 [TBL] [Abstract][Full Text] [Related]
36. Alterations in muscarinic control of striatal dopamine autoreceptors in senescence: a deficit at the ligand-muscarinic receptor interface? Joseph JA; Dalton TK; Roth GS; Hunt WA Brain Res; 1988 Jun; 454(1-2):149-55. PubMed ID: 3136856 [TBL] [Abstract][Full Text] [Related]
38. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes. DeBoer P; Abercrombie ED J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558 [TBL] [Abstract][Full Text] [Related]
39. Dopamine enhances glutamate-induced excitation of rat striatal neurons by cooperative activation of D1 and D2 class receptors. Hu XT; White FJ Neurosci Lett; 1997 Mar; 224(1):61-5. PubMed ID: 9132692 [TBL] [Abstract][Full Text] [Related]
40. Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation. Xia XG; Schmidt N; Teismann P; Ferger B; Schulz JB J Neurochem; 2001 Oct; 79(1):63-70. PubMed ID: 11595758 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]